BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2917591)

  • 21. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
    Lundgren B; Carlsson E; Herrmann I
    Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics of propranolol and atenolol in primary hyperlipidemia.
    Telatyńska B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
    Pol J Pharmacol; 2003; 55(1):81-9. PubMed ID: 12856830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
    Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
    Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in serum phosphate during beta-blockade in healthy men are not due to changes in the renal handling of phosphate.
    Kayser L; Perrild H; Jørgensen B; Fogh-Andersen N; Mølholm Hansen JE
    J Intern Med; 1989 Mar; 225(3):197-200. PubMed ID: 2649632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gas chromatographic-mass spectrometric differentiation of atenolol, metoprolol, propranolol, and an interfering metabolite product of metoprolol.
    Angier MK; Lewis RJ; Chaturvedi AK; Canfield DV
    J Anal Toxicol; 2005 Sep; 29(6):517-21. PubMed ID: 16168172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol.
    Carmona MJ; Pereira VA; Malbouisson LM; Auler JO; Santos SR
    Braz J Med Biol Res; 2009 Jun; 42(6):574-81. PubMed ID: 19448909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.
    Elliott HL; Meredith PA; McNally C; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):379-85. PubMed ID: 1777376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of atenolol vs diltiazem on the haemodynamic effects of an inhaled beta 2-adrenoceptor agonist.
    Chapman KR; Galko BM; Smith DL; Leenen FH
    Br J Clin Pharmacol; 1989 Feb; 27(2):268-71. PubMed ID: 2713221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of atenolol and metoprolol on the anticoagulant activity of acenocoumarin.
    Mantero F; Procidano M; Vicariotto MA; Girolami A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):94S-96S. PubMed ID: 6743479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular and pharmacokinetic interactions between nicorandil and adjunctive propranolol, atenolol or diltiazem in conscious dogs.
    Humphrey SJ
    Methods Find Exp Clin Pharmacol; 1998 Nov; 20(9):779-91. PubMed ID: 10022032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of substrate depletion assay for early prediction of nonlinear pharmacokinetics in drug discovery: assessment of nonlinearity of metoprolol, timolol, and propranolol.
    Komura H; Kawase A; Iwaki M
    J Pharm Sci; 2005 Dec; 94(12):2656-66. PubMed ID: 16258981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation and adverse effects of metoprolol and propranolol after concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Mutschler E
    Arch Toxicol Suppl; 1983; 6():379-83. PubMed ID: 6578746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary effects of long-term beta 2-blockade in healthy subjects: comparative study of metoprolol OROS.
    Bauer K; Rakusan S; Kaik G
    Am Heart J; 1990 Aug; 120(2):473-7. PubMed ID: 1974382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
    Agewall S; Kendall M
    J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomers.
    Hunt BA; Bottorff MB; Herring VL; Self TH; Lalonde RL
    Clin Pharmacol Ther; 1990 May; 47(5):584-91. PubMed ID: 2344707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.
    Kaiser P; Hylander B; Eliasson K; Kaijser L
    Am J Cardiol; 1985 Apr; 55(10):79D-84D. PubMed ID: 3993553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged beta blockade due to tertatolol: a comparative study with propranolol and atenolol.
    Desche P; Cournot A; Guery O; Prost JF; Duchier J
    Fundam Clin Pharmacol; 1987; 1(4):253-6. PubMed ID: 3501763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.